Ridgetech Inc

Aktienanalyse zu Ridgetech Inc (RDGT)

$1.020

+0.375 (+36.78%)Zum Schluss

Loading chart…
Hoch
1.050
Eröffnung
0.740
Volumengewichteter Durchschnittskurs
0.93
Volumen
1.27M
Marktkap.
—
Tief
0.723
Umsatz
1.19M
EV/EBITDA, TTM
0.00

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

www.jiuzhou360.com

KI-Analyse of Ridgetech Inc (RDGT)

Kaufen

Ridgetech, Inc. appears to be a good buy right now due to its recent price increase of 36.78% yesterday and a 5-day change of 27.05%. The stock is currently trading at $1.02, which is significantly below its 52-week high of $760.50, indicating potential for recovery. The RSI is at 74.734, suggesting that the stock is overbought, but the momentum could continue given the recent bullish sentiment following the reverse stock split. However, the main risk is its extreme volatility, as evidenced by a year-to-date change of -99.74%, which highlights the potential for significant price fluctuations.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Ridgetech Inc (RDGT) beträgt 1.11, verglichen mit dem 5-Jahres-Durchschnitt von 9.47.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
9.47
Aktuelles P/E
1.11
Überbewertet
33.88
Unterbewertet
-14.93

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für RDGT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%RDGT

$1.29

Szenariopreis

B

Basis

Basis · 50%RDGT

$1.24

Szenariopreis

B

Bärisch

Bärisch · 25%RDGT

$1.00

Szenariopreis

RDGT FAQ – beantwortet von Alphio AI

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors. It operates in the Consumer Cyclicals sector.

Ridgetech, Inc. appears to be a good buy right now due to its recent price increase of 36.78% yesterday and a 5-day change of 27.05%. The stock is currently trading at $1.02, which is significantly below its 52-week high of $760.50, indicating potential for recovery. The RSI is at 74.734, suggesting that the stock is overbought, but the momentum could continue given the recent bullish sentiment following the reverse stock split. However, the main risk is its extreme volatility, as evidenced by a year-to-date change of -99.74%, which highlights the potential for significant price fluctuations.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln